The serum SCC level also proved to be an independent predictor of response to neoadjuvant chemotherapy in locally advanced cervical cancer patients who received neoadjuvant chemotherapy and radical surgery [19]. This evidence concerns the gene SERPINB3 and cervical carcinoma.